相关实验视频

Updated: Jan 12, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

STAiR18对多发性骨髓瘤生存率的影响

Yingmiao Wu^1,2, Haolin Wang^1,2, Ji Luo^1,2

¹Genetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Journal of translational medicine

|November 7, 2025

概括

这项研究揭示了STAiR18通过菌miR-451a并激活IL-6R/STAT3/JAK2通路来促进多发性骨髓瘤 (MM) 细胞增殖. STAiR18为MM治疗提供了一个潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

多发性骨髓瘤 (MM) 与患者的一个子集的生存率低下和高瘤负担有关.
在MM细胞系中高STAiR18表达表明在疾病进展中起作用.
在MM中STAiR18的调控机制在很大程度上是未知的.

研究的目的:

阐明多发性骨髓瘤中STAiR18的上游和下游调节机制.
研究STAiR18在MM细胞增殖和瘤生长中的作用.
探索STAiR18作为MM的潜在治疗点.

主要方法:

定量逆转录酶PCR (qRT-PCR) 用于基因表达分析.
染色体免疫沉,然后进行定量PCR (ChIP-qPCR) 来评估转录因子结合.
光在位杂交 (FISH) 用于亚细胞局部化.
生物信息学,RNA拉下,和双化酶记者测试来验证分子相互作用.
细胞增殖试验 (CCK-8,Edu,流细胞计) 和西方抹杀用于途径分析.
在NOG小鼠的体内异种移植瘤模型中评估治疗疗效.

主要成果:

在MM患者骨髓瘤细胞中,STAiR18的表达上调,与晚期临床阶段和不良预后相关.
pSTAT3与STAiR18促进体结合,表明STAT3是一个上游调节器.
Knockdown 的 STAiR18 抑制 MM 细胞的增殖 in vitro 和瘤的生长 in vivo.
STAiR18作为miR-451a的分子海绵,通过IL-6R/STAT3/JAK2通路促进MM细胞的增殖.

结论:

通过隔离miR-451a和激活IL-6R/STAT3/JAK2正反循环,STAiR18促进了MM的扩散.
STAiR18是多发性骨髓瘤的一个有前途的治疗点.
了解STAiR18法规为MM治疗策略提供了新的途径.

关键词:

通过IL-6R/STAT3/JAK2路径进行.多发性骨髓瘤 (MM) 是一种多发性骨髓瘤.核武器的扩散在STAiR18中,它是STAiR18.在 miR-451a 里面.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...